200020012002200320042005200620072008
Pages:
12345>»
NOTICES: National Institute of Environmental Health Sciences,
Published: 2002-12-31
Notice is hereby given of a change in the meeting of the National
Institute of Environmental Health Sciences Special Emphasis Panel,
December 10, 2002, 4 p.m. to December 10, 2002, 5 p.m., which was
published in the Federal Register on November 6, 2002, FR 67: 67635.
The telephone conference call meeting will be held on January 14,
2003 at
NOTICES: Xenotransplantation Advisory Committee,
Published: 2002-12-31
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice is hereby given of a meeting of
the Board of Governors of the Warren Grant Magnuson Clinical Center.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
Part II: Health and Human Services Department, Centers for Medicare & Medicaid Services,
Published: 2002-12-31
This final rule with comment period refines the resource-based
practice expense relative value units (RVUs) and makes other changes to
Medicare Part B payment policy. In addition, as required by statute, we
are announcing the physician fee schedule update for CY 2003.
The update to the physician fee schedule occurs as a result of a
calculation
RULES: Praziquantel injectable solution,
Published: 2002-12-31
The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of an abbreviated new animal drug
application (ANADA) filed by Phoenix Scientific, Inc. The ANADA provides for the veterinary prescription
[[Page 79853]]
use of an injectable praziquantel solution in dogs and cats for the
removal of various species of
RULES: Food labeling—; Uniform compliance date,
Published: 2002-12-31
The Food and Drug Administration (FDA) is establishing January
1, 2006, as the uniform compliance date for food labeling regulations
that are issued between January 1, 2003, and December 31, 2004. FDA
periodically announces uniform compliance dates for new food labeling
requirements to minimize the economic impact of label changes. On
November 20,
NOTICES: E2C clinical safety data management; periodic safety update reports for marketed drugs; addendum,
Published: 2002-12-31
The Food and Drug Administration (FDA) is announcing the
availability of a draft guidance entitled ``Addendum to E2C Clinical
Safety Data Management: Periodic Safety Update Reports for Marketed
Drugs.'' The draft guidance was prepared under the auspices of the
International Conference on Harmonisation of Technical Requirements for
Registration of
NOTICES: National Center for Research Resources,
Published: 2002-12-31
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Research Resources Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special
NOTICES: National Eye Institute,
Published: 2002-12-31
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice is hereby given of a meeting of the National Advisory Eye Council.
[[Page 79941]]
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special
NOTICES: National Heart, Lung, and Blood Institute,
Published: 2002-12-31
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: National Institute of Allergy and Infectious Diseases,
Published: 2002-12-31
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: National Institute of Child Health and Human Development,
Published: 2002-12-31
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions
NOTICES: National Institute of Child Health and Human Development,
Published: 2002-12-31
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice is hereby given of a meeting of
the National Advisory Child Health and Human Development Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and
NOTICES: Proposed collection; comment request,
Published: 2002-12-30
The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each
NOTICES: Submission for OMB review; comment request,
Published: 2002-12-30
The Food and Drug Administration (FDA) is announcing that the
proposed collection of information listed below has been submitted to
the Office of Management and Budget (OMB) for review and clearance
under the Paperwork Reduction Act of 1995.
NOTICES: M4 common technical document; quality; questions and answers/location issues,
Published: 2002-12-30
The Food and Drug Administration (FDA) is announcing the
availability of a draft guidance entitled ``Common Technical Document
Quality: Questions and Answers/Location Issues.'' The draft guidance
was prepared under the auspices of the International Conference on
Harmonisation of Technical Requirements for Registration of
Pharmaceuticals for Human
NOTICES: New drug applications—; Diazepam Autoinjector,
Published: 2002-12-30
The Food and Drug Administration (FDA) has determined that
Diazepam Autoinjector (diazepam for injection) 5 milligrams per milliliter
[[Page 79641]]
(mg/mL) was not withdrawn from sale for reasons of safety or
effectiveness. This determination will allow FDA to approve abbreviated
new drug applications (ANDAs) for diazepam for injection 5 mg/mL.
NOTICES: Public Health Service Activities and Research at DOE Sites Citizens Advisory Committee,
Published: 2002-12-30
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92463), the Agency for Toxic Substances and
Disease Registry (ATSDR) and the Centers for Disease Control and Prevention (CDC) announce the following meeting.
Name: Citizens Advisory Committee on PHS Activities and Research
at DOE Sites: Oak Ridge Reservation
NOTICES: Proposed collection; comment request,
Published: 2002-12-30
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: Submission for OMB review; comment request,
Published: 2002-12-30
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 4981210. Send written
NOTICES: National Vaccine Advisory Committee,
Published: 2002-12-30
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92463), the Centers for Disease Control and
Prevention (CDC) announces the following Federal advisory committee meetings.
Name: National Vaccine Advisory Committee (NVAC).
Times and Dates: 9 a.m.5 p.m., February 4, 2003; 8:30 a.m.3
p.m., February 5, 2003.
NOTICES: Medicare Coverage Advisory Committee,
Published: 2002-12-27
This notice announces the renewal and amendment of the Charter
of the Medicare Coverage Advisory Committee (the Committee). The
Committee advises the Secretary of the Department of Health and Human
Services (the Secretary) and the Administrator of the Centers for
Medicare & Medicaid Services on whether adequate evidence exists to
determine whether
RULES: National Vaccine Injury Compensation Program; materials related to petitions; service of process,
Published: 2002-12-27
Current regulations regarding service of legal process provide
that all service of process relating to petitions for compensation
under the National Vaccine Injury Compensation Program (VICP) are to be
sent to the Director, Bureau of Health Professions (BHPr), Health
Resources and Services Administration (HRSA). Because the Acting
Administrator,
NOTICES: State plan amendments, reconsideration; hearings—; New Jersey,
Published: 2002-12-27
This notice announces an administrative hearing to be held on
February 4, 2003, 10 a.m., Centers for Medicare & Medicaid Services'
New York Regional Office, 26 Federal Plaza, Room 38110A; New York, New
York 102780063, to reconsider our decision to disapprove New Jersey
State Plan Amendment 0210.
NOTICES: Program issuances and coverage decisions; quarterly listing,
Published: 2002-12-27
This notice lists CMS manual instructions, substantive and
interpretive regulations, and other Federal Register notices that were
published from July 2002, through September 2002, relating to the
Medicare and Medicaid programs. This notice also provides information
on national coverage determinations affecting specific medical and
health care
NOTICES: Medicare+Choice organizations—; Risk adjustment; training sessions,
Published: 2002-12-27
This notice announces a national Medicare+Choice risk
adjustment public meeting for Medicare+Choice organizations, Medicare
capitated demonstration projects, PACE plans, Evercare plans, Social
Health Maintenance Organizations, Wisconsin Partnership program,
Minnesota Senior Health Options, providers, practitioners, and other
interested parties.